PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “PULMONARY EMBOLISM”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 127 records · Page 7Linked to original sources

Measurement of diffusing capacity in pulmonary embolism.

Pulmonary function tests were carried out in 20 consecutive patients with pulmonary embolism (PE), diagnosed on the basis of a positive ventilation-perfusion lung scan carried out within 72 h of admission. Changes in forced expiratory volume in one second (FEV1), forced vital capacity (FVC) and arterial blood gas tensions were too variable to be helpful diagnostically. In contrast, transfer factor (diffusing capacity) of the lung (TLCO) was significantly reduced in all cases and, in spite of a period of anticoagulation, tended to remain subnormal during a follow-up period of up to 3 years. Lung scans, however, tended to return to normal within 3 months of the incident. Thus, a reduction of TLCO to below 75% of the predicted normal was found in all cases with abnormal lung scans and such measurements provide a useful and simple screening test for PE; a normal TLCO would effectively exclude such a diagnosis. The failure of TLCO to return to normal in the majority of cases suggests persistence of the underlying physiological defect, in spite of normalization of symptoms and lung scans following anticoagulation.

Adult↗

Risk factors for the assessment of patients with pulmonary embolism.

Pulmonary embolism (PE) occurs frequently among cancer patients, with a spectrum ranging from small, clinically insignificant thrombi to life-threatening massive PE. It is fatal in as many as 14% of cancer patients, primarily by producing right ventricular heart failure and cardiogenic shock. PE diagnosis is difficult because the signs and symptoms imitate other commonly occurring diseases. Clinicians must be able to integrate a wide array of diagnostic imaging tools and laboratory tests to ensure rapid assessment and diagnosis. Risk stratification with the use of cardiac biomarkers and imaging tests to evaluate right ventricular function will identify treatment options. Hemodynamically stable patients can be treated effectively with anticoagulation alone, whereas those with right ventricular dysfunction require an aggressive strategy with thrombolysis, surgical embolectomy, or a catheter-based intervention. When anticoagulation is contraindicated, a vena caval filter may be deployed. PE treatment must be customized to the individual and consider the existing thrombus burden, presence of underlying cardiopulmonary disease and right side heart dysfunction, and cancer status of the patient. Clinicians should focus on providing adequate thromboprophylaxis in hospitalized cancer patients to avoid PE treatment.

Humans↗

Risk factors for adverse short-term outcome in patients with pulmonary embolism.

Pulmonary embolism (PE) is a common and potentially fatal disease. Death usually occurs before hospital admission or in the initial in-hospital phase. A number of clinical and instrumental findings have been associated with a high risk of adverse short-term clinical outcomes in patients with PE. Advanced age, concomitant cardiopulmonary disease, and haemodynamic instability, as well as large perfusion defects at lung scanning and acute right heart dysfunction as assessed by echocardiography, are associated with adverse in-hospital outcome. Elevated serum levels of troponin I have been recently demonstrated to be associated with severe right ventricular dysfunction and adverse in-hospital outcome in patients with PE. Early recurrence of PE is associated with a high mortality rate. Right heart dysfunction, as assessed by echocardiography and an acute fall in platelet count, have been suggested as risk factors for recurrence of PE. A reduction in mortality in the subgroup of patients with a poor prognosis might be achieved by using more aggressive treatments such as thrombolysis and surgical or interventional procedures. However, such treatments are invariably associated with bleeding and other procedural complications.

Humans↗

V/Q-scanning/SPECT for the diagnosis of pulmonary embolism.

Pulmonary embolism (PE) is visualized indirectly by perfusion (Q) scanning as a parenchymal defect related to the embolized artery, and is confirmed by combined ventilation (V) scanning, showing a normal regional ventilation. Based on its principle of detection, V/Q scanning is able to show even small emboli and this ability is enhanced by SPECT. Compared to angiography, V/Q scanning seems to be burdened with low specificity, whereas its sensitivity is sufficiently high. Correlation of V/Q scanning with single-slice CT is comparable with that with angiography. The positive predictive value of V/Q scanning cannot be assessed by the reference standard angiography or by single-slice CT because both have turned out to be inadequate. Correlation of V/Q scanning with high-resolution CT is very promising, revealing high sensitivity as well as specificity of V/Q scanning, but this needs further evaluation in larger studies. Nevertheless, the use of V/Q scanning as a one-step diagnostic approach to PE is unrestricted in patients with normal chest radiograph, whereas V/Q scanning in combination with spiral CT is recommended in patients with abnormal chest radiograph. The negative predictive value of V/Q scanning for recurrent PE is unsurpassed high and by this, V/Q scanning tends to be used primarily to exclude rather than confirm PE.

Animals↗

Diagnostic value of arterial blood gas measurement in suspected pulmonary embolism.

Pulmonary embolism (PE) is a common and lethal yet treatable condition. Several authors have reported on the diagnostic value of combinations of arterial blood gas (ABG) and other clinical data (i. e., prediction rules), and have claimed that these combinations can be safely used to exclude PE. The purpose of this investigation was to evaluate the diagnostic value of ABG measurement and to attempt to validate the ABG prediction rules published by these various authors for the assessment of patients with suspected PE. Two hundred ninety-three consecutive patients referred for imaging to investigate suspected PE were approached to participate in the investigation. ABG and other clinical data were obtained from consenting and eligible patients before an outcome classification (PE versus non-PE) was performed. None of the ABG data or prediction rules had sufficient negative predictive value, specificity, or likelihood ratios to be useful in the management of patients with suspected PE. We conclude that ABG data alone or in combination with other clinical data are not useful in the assessment of suspected PE.

Arteries↗

Radionuclide imaging of acute pulmonary embolism.

Pulmonary embolism (PE) is a potentially fatal condition for which treatment is highly effective. The diagnosis of PE can be challenging and often requires diagnostic imaging. For many years, chest radiographs and ventilation-perfusion (V/Q) scintigraphy have been the primary imaging modalities used in the evaluation of patients with suspected acute PE. The combination of clinical assessment, plus results of V/Q scintigraphy and a noninvasive venous study of the lower extremities can provide clinicians with the information needed to direct treatment in the majority of patients with suspected PE. More recently, advances in computerized tomography (CT) angiography have allowed for the direct visualization of PE, and this technique has emerged as an important diagnostic test in the evaluation of patients with suspected PE. Proponents suggest that CT angiography should be used as the first line imaging test in patients with suspected PE. Others suggest that V/Q scanning should remain as the first line diagnostic imaging test and that CT angiography should be used in patient's in whom the diagnosis remains uncertain. The combination of CT angiography and CT venography has the potential to provide a single comprehensive study of patients with suspected venous thromboembolism.

Acute Disease↗

Optimizing anticoagulant therapy in the management of pulmonary embolism.

Pulmonary embolism (PE) continues to command a high price in terms of mortality and recurrence, despite full-dose initial anticoagulation and long-term warfarin therapy. Embolectomy, thrombolysis, and vena cava filters may be life saving in patients with massive PE and cardiogenic shock, but their use in other groups remains controversial. Recent progress has been made in identifying key markers of a poor prognosis; these markers may assist in tailoring treatment to patient risk. In particular, right ventricular dysfunction, detected using echocardiography, may portend an ominous prognosis for patients without hemodynamic instability. Thrombolysis may be beneficial in this group, although concerns about bleeding risk remain to be clarified. Low molecular weight heparins (LMWHs) have recently been shown to be as effective as unfractionated heparin in the initial treatment of PE. One agent has now received a limited approval from the United States Food and Drug Administration for use in certain low-risk patients, mostly those with asymptomatic PE in the presence of concomitant deep-vein thrombosis. Although enoxaparin for PE treatment is currently licensed for therapy exclusively in the hospital setting, brief hospitalization or home treatment for nonmassive PE may be possible in the future. Expert management of long-term warfarin therapy is also crucial to optimize clinical outcomes. Recognition of potential causes of excessive anticoagulation and the use of self-monitoring by patients may improve the efficacy and safety of long-term warfarin administration.

Anticoagulants↗

Electrocardiography and Wells scoring in predicting the anatomic severity of pulmonary embolism.

Pulmonary embolism (PE) is a major health problem associated with a significant morbidity and mortality. Immediate recognition of submassive and massive cases is extremely important in order to commencement of early and appropriate therapy that could be life saving. The aim of this study was to assess the ability of two scoring systems, electrocardiography (ECG) and simplified Wells (sWells) clinical scorings in predicting anatomic severity of PE. Hence, ECG and sWells scorings were combined in order to test the hypothesis if this new scoring does enhance the prediction of severity. Fifty six patients with proven PE with high (50 patients) and moderate (six patients)-probability of ventilation/perfusion (V/Q) scan were retrospectively studied. Baseline ECGs were analysed by two independent observers in order to constitute ECG scorings. Baseline sWells scores were also calculated. Anatomic severity of PE was calculated by scintigraphically and categorized into mild (<50% perfusion defect) (group 1), and severe (50% perfusion defect) (group 2) diseases. The mean of ECG scores, sWells scores and the combined scores were 5.23+/-3.42 and 5.85+/-3.82; 6.60+/-1.88 and 7.03+/-2.40; and 10.73+/-3.60 and 11.60+/-4.32 in groups 1 and 2, respectively (p>0.05). An ECG score of 6.5 predicted severe disease (perfusion defect 50%) with a sensitivity of 41.7% and a specificity of 82%). sWells and combined scores did not provide better sensitivity or specificity values based on ROC curve analysis. Our results indicated that ECG scoring could be valuable test in predicting anatomic severity of PE, adding sWells scoring to ECG scoring did not provide any beneficial effect.

Adult↗

[Comparison between D-dimer levels and lung scan in patients with suspected pulmonary embolism].

Pulmonary embolism (PE) is a critical situation that requires prompt diagnosis and treatment. Lately, the use of D-Dimer (DD) blood level test was recommended when PE is suspected. The goal of this work was to evaluate the association between DD levels and the results of lung scan in patients with suspected PE. 84 patients who were admitted due to suspected PE and met the inclusion criteria of having both DD test and lung scan within less than 7 days apart, were included in our study (age = 76 +/- 14, females = 58, males = 26). Comparison of lung scan results, DD level and diagnosis of PE at discharge was carried out. The subjects were classified into 2 groups according to the DD levels: group A = DD > or = 250 ng/mL--abnormal test, group B = DD < 250 ng/mL--normal test. Group A includes 67 patients, of which 29 (43%) were diagnosed as PE. In these subgroup lung scan showed high Probability (HP) for PE in 19 (66%), medium probability (MP) in 9 (31%) and low probability (LP) in 1 (3%). From the 38 (57%) patients who were not diagnosed with PE (non-PE), 5 (13%) had HP lung scan, 4 (11%) MP and 29 (76%) LP. Group B includes 17 patients, in which only one (6%) had diagnosed with PE and the rest (n = 16, 94%) had no PE. Of the latter subgroup 15 (94%) had LP lung scan and one MP scan. The one patient who was diagnosed with PE had a HP lung scan that was also confirmed with CT-angiography. DD and lung scan had similar sensitivity (96.7%) and high negative predictive value (NPV = 94.1% and 97.8% accordingly) for PE. On the other hand DD specificity is much lower (29.6%) in comparison to lung scan (81.5%). The results of this work support the use of DD test prior to lung scan, in order to rule out PE with relatively high probability.

Aged↗

A comparison of spiral computed tomography and latex agglutination D-dimer assay in acute pulmonary embolism using pulmonary arteriography as gold standard.

OBJECTIVE: To compare the diagnostic accuracy of contrast medium enhanced spiral computed tomography of the pulmonary arteries (s-CTPA) and a latex agglutination D-dimer assay in patients with suspected acute pulmonary embolism (PE) by using pulmonary arteriography (PA) and clinical follow-up as reference method. DESIGN: Ninety hemodynamically stable patients with symptoms of acute pulmonary embolism were prospectively evaluated with s-CTPA and pulmonary arteriography (PA) within 24 h from admission. Plasma D-dimer levels on admittance were analyzed using a rapid latex agglutination D-dimer assay. The outcome of D-dimer concentrations in plasma below 0.25 and 0.5 mg/l was studied. RESULTS: All PA and s-CTPA investigations were regarded as of acceptable diagnostic quality in a consensus reading. Thirty-three patients had a positive PA (37%). Three patients had false negative and two patients had false positive s-CTPA findings. s-CTPA had 91% sensitivity, 96% specificity, 94% positive predictive value (PPV) and 95% negative predictive value (NPV). The sensitivity and specificity for D-dimer below 0.5 mg/l were 79 and 88%, respectively. The PPV and NPV were 81 and 87%. If a cut-off level of 0.25 mg/l was used the corresponding figures were 91, 65, 63 and 92%. CONCLUSION: s-CTPA has a higher sensitivity and specificity than latex agglutination D-dimer. A cut-off level of 0.25 mg/l can be used as screening method, but s-CTPA must be performed to exclude false positive cases.

Adolescent↗

[Prevention of pulmonary embolism].

Pulmonary embolism (PE) is one of the most common causes of death in hospitalized patients. Several groups of patients at high risk of developing venous thromboembolic complications have been identified. The effect of primary prophylaxis on the incidence of fatal PE has been demonstrated only in a few studies, while evidence for a benefit of pharmacologic and physical modalities of prophylaxis in preventing venous thrombosis has been documented in many prospective randomized clinical trials. The preventive measures differ according to the type of patient at risk, and in some groups of patients at risk several prophylactic regimen can be used. Application of low-dose heparin is the best documented prophylactic modality. General primary prophylaxis in 100 patients at risk could save one life. However, low-dose heparin is of limited efficacy in patients at high risk for thromboembolism. The following anithrombotic regimens are recommended in these patients: adjusted - dose heparin; oral anticoagulants with low intensity of anticoagulation; dextran; heparin in combination with dihydroergotamine; low-molecular-weight heparin fractions (LMWH). It is likely that prevention with LMWH will become the most important prophylactic modality in the near future. Mechanical methods of prophylaxis should be used primarily in combination with pharmacologic prevention. In low-risk patients mechanical methods alone offer sufficient prophylaxis. Low-dose heparin which is effective for primary prevention is not effective in secondary prophylaxis to prevent extension or embolization of established thrombosis. Inadequate anticoagulant therapy results in increased risk of recurrent thromboembolism. The general application of primary prophylaxis in patients at risk is superior to secondary prophylaxis with treatment of established thromboembolism.

Anticoagulants↗

Effects of pulmonary embolism on pulmonary vascular impedance in dogs and minipigs.

Pigs have been reported to present with a stronger pulmonary vascular reactivity than many other species, including dogs. We investigated the pulmonary vascular impedance response to autologous blood clot embolic pulmonary hypertension in anesthetized and ventilated minipigs (n = 6) and dogs (n = 6). Before embolization, minipigs, compared with dogs, presented with higher mean pulmonary arterial pressure (Ppa; by an average of 9 mmHg), a steeper slope of Ppa-flow (Q) relationships, and higher 0-Hz impedance (Z0) and first-harmonic impedance (Z1), without significant differences in characteristic impedance (Zc), and a lower ratio of pulsatile hydraulic power to total hydraulic power. Embolic pulmonary hypertension (mean Ppa: 40-55 mmHg) was associated with increased Z0 and Z1 in both species, but the minipigs had a steeper slope of Ppa/Q plots and an increased Zc. At identical Q and Ppa, minipigs still presented with higher Z1 and Zc and a lower ratio of pulsatile hydraulic power to total hydraulic power. The energy transmission ratio, defined as the hydraulic power in the measured waves divided by the hydraulic power in the forward waves, was better preserved after embolism in minipigs. No differences in wave reflection indexes were found before and after embolism. We conclude that minipigs, compared with dogs, present with a higher pulmonary vascular resistance and reactivity and adapt to embolic pulmonary hypertension by an increased Zc without earlier wave reflection. These differences allow for a reduced pulsatile component of hydraulic power and, therefore, a better energy transfer from the right ventricle to the pulmonary circulation.

Animals↗

The prevalence of pulmonary embolism and pulmonary hypertension in patients with type II diabetes mellitus.

BACKGROUND: Patients with diabetes mellitus (DM) have a hypercoagulable state that may increase their risk for thromboembolism. However, the data about this association are contradictory in the literature. The goal of this study was to evaluate the occurrence of pulmonary embolism (PE) and pulmonary hypertension (PHT) in patients with DM after adjusting for coronary artery disease (CAD), congestive heart failure (CHF), hypertension, and smoking using a large database. METHOD: We used patient treatment file documents to inpatient hospital admissions containing discharge diagnoses (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] codes) from Veterans Health Administration Hospitals. The patients were classified into two groups: a DM group with an ICD-9-CM code for DM (293,124), and a control group with an ICD-9-CM code for hypertension but no DM (552,623). The ICD-9-CM code for PE (415.19) and the ICD-9-CM code for PHT (416.0) were used to study prevalence of these diseases in DM patients vs control patients. We performed univariate and multivariate analyses adjusting for CAD, CHF, and smoking. Continuous variables were analyzed by unpaired t test. Binary variables were analyzed by chi(2) and Fisher exact tests. RESULTS: PE was present in 2,011 patients with DM (0.7%) vs 2,759 patients (0.5%) in the control group. PHT was present in 3,356 patients with DM (1.1%) vs 3,357 patients (0.6%) in the control group. Using multivariate analysis, DM remained independently associated with PE (odds ratio [OR], 1.27; 95% confidence interval [CI], 1.19 to 1.35; p < 0.001) and with PHT (OR, 1.53; 95% CI, 1.45 to 1.60; p < 0.001). CONCLUSION: Patients with DM have significantly higher prevalence of PE and PHT independent of CAD, hypertension, CHF, or smoking. The pathogenesis of this association is not known at this time.

Aged↗

Successful thrombolysis for massive pulmonary embolism after pulmonary resection.

We report the successful use of thrombolysis for acute massive pulmonary embolism 2 days after right lower lobectomy for bronchial adenocarcinoma. Pulmonary angiography revealed extensive clot unsuitable for surgical embolectomy. A bolus infusion of recombinant tissue plasminogen activator produced an immediate improvement in the patient's hemodynamic state. There was substantial blood loss requiring the transfusion of 21 units of blood over the postoperative period. The patient made a successful recovery and remained well at 1 year.

Adenocarcinoma, Mucinous↗

Crack cocaine mimicking pulmonary embolism on pulmonary ventilation/perfusion lung scan. A case report.

Cocaine inhalation is associated with multiple pulmonary complications including pulmonary infiltrates, pulmonary edema, barotrauma, tracheal injury, and alveolar hemorrhage. Little has been reported about ventilation/perfusion (V/Q) lung scanning in patients who smoke cocaine. The authors report a case of inhalation cocaine abuse mimicking pulmonary embolism by V/Q scan criteria. This case report documenting perfusion abnormalities within hours of cocaine smoking which resolved within days provides the first in vivo evidence for pulmonary vasoconstriction.

Adult↗

Recurrent pulmonary embolism and pulmonary hypertension in chronic tetraplegia.

STUDY DESIGN: Case report. OBJECTIVE: To describe an unusual case of progressive pulmonary hypertension due to recurrent pulmonary embolism in a chronically paralyzed spinal cord injury patient. SETTING: Veterans Administration Hospital, West Roxbury, MA, USA. SUBJECT: A 57-year-old man, tetraplegic, sensory incomplete and motor complete for 30 years due to a diving accident, complained of lightheadedness and shortness of breath intermittently for 7 years. Examination during the latest episode revealed anxiety, confusion, respirations 28 per min, blood pressure 80/60 mmHg, and arterial pH 7.41, P(CO2) 28 mmHg, P(O2) 95 mmHg on 2 l of oxygen. A chest film 2 weeks earlier had revealed a right-sided cutoff of pulmonary vasculature; the current film showed right-sided pleural effusion. Review of EKGs showed a trend of increasing right axis deviation with recovery and recurrences during the previous 9 years and a current incomplete right bundle branch block with clockwise rotation and inverted T waves in V1-4. Computerized tomography with contrast material revealed small pulmonary emboli, but only in retrospect. The patient died shortly after scanning. AUTOPSY: The pulmonary arteries were free of thromboemboli on gross examination but medium and small-sized arteries were constricted or obliterated with thrombotic material microscopically. The estimated ages of the thromboemboli ranged from days to years. The right ventricle was hypertrophied; the coronary arteries were patent. CONCLUSION: Recurrent pulmonary emboli resulted in chronic pulmonary hypertension and eventual death in a patient with chronic tetraplegia.

Chronic Disease↗